14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ARX vs ERIE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Erie Indemnity Co (ERIE) is the stronger overall head-to-head candidate over Accelerant Holdings (ARX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas ERIE carries 47.8/100 (HOLD) at $275.90 (20.7x Forward P/E, 18.3% operating margin).
Competes within the Insurance Brokers value chain with $14.4B market capitalization and 18.3% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ARX vs ERIE Key Questions & Quantitative Answers
As of Nov 16, 2026, Erie Indemnity Co (ERIE) is the stronger overall head-to-head candidate over Accelerant Holdings (ARX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). ARX carries a Unified Composite Score of 46.9/100 (HOLD) at $19.87 (21.3x Forward P/E, 3.7% operating margin), whereas ERIE carries 47.8/100 (HOLD) at $275.90 (20.7x Forward P/E, 18.3% operating margin). Technically, ARX sits in a Markup phase (RSI 69.8, CONSOLIDATION options structure) and ERIE sits in a Markup phase (RSI 63.6, SURGE options structure).
ARX leads the Growth & Scale pillar: ARX posts +6.1% YoY revenue growth and +800.0% YoY earnings growth on $2.79B TTM revenue (62.8% gross margin, 3.7% operating margin), compared with ERIE at +0.3% YoY revenue growth and -0.5% YoY earnings growth on $4.12B TTM revenue (17.9% gross margin, 18.3% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ARX cumulative revenue shifted +167.6% while ERIE shifted +71.0%. In operating R&D and SG&A reinvestment, ARX deploys 59.1% of Rev ($1.65B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ERIE.
ERIE screens cheaper on headline valuation multiples. ARX trades at 21.3x Forward P/E, 27.6x Trailing P/E, N/M PEG, and N/M EV/Revenue (22.7% FCF margin), whereas ERIE trades at 20.7x Forward P/E, 24.9x Trailing P/E, 2.67x PEG, and 3.5x EV/Revenue (13.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARX (9.2% ROE) versus ERIE (23.7% ROE) capital efficiency.
In options market volatility and institutional positioning, ARX carries 15.7% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.19β · 2% Vol realized risk). By comparison, ERIE carries 38.9% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.51β · 38% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.